Ascendis Pharma A/S
TransCon hGH
idiopathic short stature (ISS), SHOX deficiency, Turner syndrome, and small for gestational age (SGA)
Date
TBD
Phase 3 readout · Date TBD estimated
What's at stake
Phase 3 trial results for TransCon hGH in idiopathic short stature (ISS), SHOX deficiency, Turner syndrome, and small for gestational age (SGA) are due Date TBD. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 6-K
verified 13h ago
“Initiated Phase 3 basket trial for additional indications: idiopathic short stature (ISS), SHOX deficiency, Turner syndrome, and small for gestational age (SGA).”